KHALID MALIK
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- MOUNT PLEASANT, TX
- NPI
- 1407880305
- Received
- $16,335 in 97 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 68 | $1,302 |
| 2024 | General payment | 2 | $36 |
| 2023 | General payment | 4 | $4,075 |
| 2022 | General payment | 8 | $6,033 |
| 2021 | General payment | 7 | $3,496 |
| 2020 | General payment | 6 | $1,290 |
| 2019 | General payment | 2 | $99 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 37 | $13,060 | 2021–2025 |
| Allergan, Inc. | 8 | $2,132 | 2020–2022 |
| Lundbeck LLC | 11 | $236 | 2025 |
| Novartis Pharmaceuticals Corporation | 14 | $218 | 2025 |
| Genentech USA, Inc. | 4 | $169 | 2019–2025 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 | 2025 |
| Eisai Inc. | 3 | $88 | 2025 |
| Axsome Therapeutics, Inc. | 3 | $72 | 2025 |
| MDD US Operations, LLC | 3 | $59 | 2024–2025 |
| Biogen, Inc. | 2 | $48 | 2025 |
| UCB, Inc. | 1 | $28 | 2025 |
| SK Life Science, Inc. | 1 | $28 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 2 | $26 | 2019–2022 |
| Life Molecular Imaging Ltd | 1 | $22 | 2025 |
| PFIZER INC. | 1 | $21 | 2025 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 | 2025 |
| Lilly USA, LLC | 1 | $15 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 10 | $13,225 |
| Food and Beverage | 85 | $1,889 |
| Travel and Lodging | 1 | $1,211 |
| Education | 1 | $9 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | ABBVIE INC. | $9 | Education | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-12-16 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-12-15 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-12-15 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-12-11 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2025 | |
| 2025-11-19 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-11-18 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-11-11 | Genentech USA, Inc. | $34 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-11-06 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-11-05 | Biogen, Inc. | $21 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2025 | |
| 2025-11-04 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-29 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-10-21 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-10-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-10-14 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | Genentech USA, Inc. | $26 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-10-06 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-01 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2025 | |
| 2025-09-25 | Lundbeck LLC | $26 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-23 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-16 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-09-10 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-09 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-28 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | AMYVID Drug, Neuroscience | 2025 | |
| 2025-08-27 | Eisai Inc. | $29 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-08-21 | SK Life Science, Inc. | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-19 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-19 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-14 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-08-14 | Novartis Pharmaceuticals Corporation | $1 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-08-04 | Genentech USA, Inc. | $20 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-07-31 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-07-30 | Novartis Pharmaceuticals Corporation | $4 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-07-25 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-17 | Lundbeck LLC | $27 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-07-08 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-26 | Axsome Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-06-25 | Biogen, Inc. | $27 | Food and Beverage | In-kind items and services | SKYCLARYS Drug, Neurology | 2025 | |
| 2025-06-24 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-06-24 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-06-12 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-05-20 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-05-13 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-06 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-05-05 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-29 | Teva Pharmaceuticals USA, Inc. | $27 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2025 | |
| 2025-04-17 | Lundbeck LLC | $29 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-04-15 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-10 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-04-02 | Eisai Inc. | $30 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-03-20 | MDD US Operations, LLC | $22 | Food and Beverage | In-kind items and services | Gocovri Drug, AMANTADINE | 2025 | |
| 2025-03-19 | Eisai Inc. | $27 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-03-18 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-18 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-18 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-12 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-02-26 | Life Molecular Imaging Ltd | $22 | Food and Beverage | Cash or cash equivalent | NEURACEQ Drug, Diagnostic Tracer | 2025 | |
| 2025-02-25 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-02-21 | Lundbeck LLC | $27 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-02-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-02-20 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-02-13 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-01-30 | UCB, Inc. | $28 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-01-22 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2025 | |
| 2024-11-04 | MDD US Operations, LLC | $22 | Food and Beverage | In-kind items and services | Gocovri Drug, AMANTADINE | 2024 | |
| 2024-10-07 | MDD US Operations, LLC | $13 | Food and Beverage | In-kind items and services | Gocovri Drug, AMANTADINE | 2024 | |
| 2023-06-07 | ABBVIE INC. | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-02 | ABBVIE INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-05-15 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-05-09 | ABBVIE INC. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2022-11-16 | ABBVIE INC. | $1,211 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-11-16 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-10-27 | ABBVIE INC. | $2,275 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-10-27 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-09-14 | Allergan, Inc. | $91 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-07-12 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2022 | |
| 2022-01-27 | ABBVIE INC. | $2,275 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-01-27 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2021-10-20 | ABBVIE INC. | $1,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-20 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-14 | ABBVIE INC. | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-08-23 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-05-19 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-04-08 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-01-08 | Allergan, Inc. | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2020-11-05 | Allergan, Inc. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-09-09 | Allergan, Inc. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-08-12 | Allergan, Inc. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-08-11 | Allergan, Inc. | $975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-05-05 | Allergan, Inc. | $200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-02-13 | Allergan, Inc. | $65 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2019-04-08 | Genentech USA, Inc. | $87 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-03-25 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Mount Pleasant, TX, county Titus County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Mount Pleasant, TX | County Titus County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 16,136 | 31,363 | 30,188,424 |
| Population, 2020 census P1 | 16,047 | 31,247 | 29,145,505 |
| Median age B01002 | 30.1 | 34.9 | 35.6 |
| Under 18 B01001 | 32.1% | 28.2% | 25.0% |
| 65 and over B01001 | 11.3% | 15.2% | 13.4% |
| Households B11001 | 5,584 | 11,156 | 10,992,816 |
| Foreign born B05002 | 20.4% | 18.4% | 17.6% |
| Median household income B19013 | $50,515 | $58,425 | $78,476 |
| Median family income B19113 | $59,000 | $72,536 | $94,599 |
| Per capita income B19301 | $23,814 | $27,244 | $40,752 |
| Poverty rate B17001 | 18.3% | 17.1% | 13.8% |
| Unemployment rate B23025 | 2.5% | 3.1% | 5.3% |
| Civilian labor force B23025 | 7,384 | 14,387 | 15,233,563 |
| Mean commute (minutes) B08013 | 16.0 | 20.3 | 26.7 |
| Bachelor's degree or higher B15003 | 12.5% | 16.3% | 33.8% |
| Housing units B25001 | 5,877 | 12,146 | 12,128,515 |
| Owner-occupied B25003 | 58.0% | 70.6% | 62.6% |
| Renters B25003 | 42.0% | 29.4% | 37.4% |
| Median home value B25077 | $170,700 | $174,000 | $283,800 |
| Median gross rent B25064 | $910 | $907 | $1,403 |
| White, not Hispanic B03002 | 26.6% | 42.4% | 39.1% |
| Black B03002 | 16.9% | 10.2% | 11.9% |
| Hispanic or Latino B03002 | 54.8% | 45.0% | 39.7% |
| Asian B03002 | 0.0% | 0.0% | 5.5% |
| American Indian and Alaska Native B03002 | 0.2% | 0.3% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Mount Pleasant, TX.
Comments